Multicenter analytical performance evaluation of the Elecsys® proBNP assay

Clinical Chemistry and Laboratory Medicine

Volumn 42, Issue 8, 2004, Pages 965-972

  Sokoll, Lori J ^a   Baum, Hannsjörg ^b   Collinson, Paul O ^c   Gurr, Eberhard ^d   Haass, Markus ^e   Luthe, Hilmar ^f   Morton, James J ^g   Nowatzke, William ^h   Zingler, Christiana ⁱ  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c ST GEORGE S HOSPITAL   (United Kingdom)

^d Klinikum Links der Weser   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f UNIVERSITY OF GÖTTINGEN   (Germany)

^g UNIVERSITY OF GLASGOW   (United Kingdom)

^h WASHINGTON UNIVERSITY   (United States)

ⁱ UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Analytical performance; Brain natriuretic peptide (BNP); Congestive heart failure; NT proBNP; proBNP

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; HEPARIN; POLYCLONAL ANTIBODY; PROTEIN PRECURSOR;

ANALYTIC METHOD; ANTIBODY SPECIFICITY; ARTICLE; CHEMOLUMINESCENCE; CIRCADIAN RHYTHM; CLINICAL LABORATORY; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ELECTROCHEMICAL ANALYSIS; ENZYME IMMUNOASSAY; FREEZING; GEL; HUMAN; INTERMETHOD COMPARISON; LABORATORY AUTOMATION; LINEAR SYSTEM; MULTICENTER STUDY; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN STABILITY; REPRODUCIBILITY; THAWING;

CHEMILUMINESCENT MEASUREMENTS; EVALUATION STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; IMMUNOASSAY; NATRIURETIC PEPTIDE, BRAIN; NERVE TISSUE PROTEINS; PEPTIDE FRAGMENTS; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 4444367034     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2004.157     Document Type: Article

References (20)

1. Kirkwood F, Adams J. New epidemiological perspectives concerning mild-to-moderate heart failure. Am J Med 2001;110:6S-13S
2. Kannel WB, Belanger AJ. Epidemiology of heart failure. Am Heart J 1991;121:951-7
3. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971;285:1441-6
4. Remes JMH, Reunamen APK. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 1991;12:315-21
5. Struthers AD. The diagnosis of heart failure. Heart 2000;84:334-8
6. Ambrose TM. Review of the clinical utility of NT-proBNP in the diagnosis, prognosis, and therapy monitoring of patients with congestive heart failure. J Clin Ligand Assay 2002;25:160-6
7. Mair J, Hammerer-Lercher A, Puschendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med 2001;39:571-88
8. Remme WJ, Swedberg K. Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001;22:1527-60
9. Hunt P, Richards A, Nicholls M, Yandle TG, Doughty R, Espiner EA. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin Endocrinol 1007;47:287-96
10. Wu AH, Smith A, Wieczorek S, Mather JF, Duncan B, White CM, et al. Biological variation for N-terminal pro-and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol 2003;92:628-31
11. Dasgupta A, Chow L, Tso G, Nazareno L. Stability of NTproBNP in serum specimens collected in Becton Dickinson vacutainer (SST) tubes. Clin Chem 2003;49:958-60
12. Masson S, Vago T, Baldi G, Salio M, DeAngelis N, Nicolis E, et al. Comparative measurement of N-terminal probrain natriuretic peptide and brain natriuretic peptide in ambulatory patients with heart failure. Clin Chem Lab Med 2002;40:761-3
13. Bluestein BI, Despres N, Belenky A, Ghani F, Armstrong EG. BNP in the diagnosis of heart failure. Advance Laboratory 2003;12:63-72
14. ProBNP product insert. Elecsys Systems. Roche Diagnostics, 2003-3
15. Karl J, Borgaya A, Gallusser A, Huber E, Krueger K, Rollinger W, et al. Development of a novel, N-terminalproBNP (NT-proBNP) assay with a low detection limit. Scand J Clin Lab Invest 1999;59(Suppl 230):177-81
16. Murdoch DR, Byrne J, McDonagh T, Morton JJ, McMurray JJV. Measurement of brain natriuretic peptide. Lancet 1996;348:1588-9
17. BNP product insert. ADVIA Centaur. Bayer HealthCare LLC, 2003-06, Rev. C
18. BNP product insert. Triage BNP. Biosite Diagnostics, 2001, Rev. B
19. Nowatzke WL, Cole TG. Stability of N-terminal pro-brain natriuretic peptide after storage frozen for one year and after multiple freeze-thaw cycles. Clin Chem 2003;49:1560-2
20. Mair J. Role of cardiac natriuretic peptide testing in heart failure. Clin Chem 2002;48:977-8